Symbol: |
BCL2L10
|
Description: |
BCL2-like 10 (apoptosis facilitator) [Source:HGNC Symbol;Acc:993]
|
Location: |
Chr15:52401460-52404972[-]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:124
Gene |
Compound |
Gen_sig |
Exp_pattern |
BCL2L10 |
11H-Indeno[1,2-c]isoquinolinium, 9-hydroxy-2,3,8-trimethoxy-6-methyl-, chloride |
0.006 |
Down |
BCL2L10 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.001 |
Down |
BCL2L10 |
Maxima isoflavone D |
0.011 |
Down |
BCL2L10 |
C.I. 37559 |
0.039 |
Down |
BCL2L10 |
NSC 58903 |
0.009 |
Down |
BCL2L10 |
14-FLUORO-4-DEMETHOXYDAUNORUBICIN |
0.01 |
Down |
BCL2L10 |
Imidazo[2,1-b]thiazole-5-carboxamide, N-[(4-chlorophenyl)-aminocarbonyl]- |
0.008 |
Down |
BCL2L10 |
4,8-Ethenobenzo[1,2-c:4,5-c']dipyrrole-1,3,5,7-tetrone, 2,6-bis(3-cyanophenyl)-1,2,3,3a,4,4a,5,6,7,7a,8,8a- dodecahydro- |
0.019 |
Down |
BCL2L10 |
NSC 639211 |
0.027 |
Down |
BCL2L10 |
Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)phenyl] ethylidene]-5-[(1-piperidinyl)methyl]-, hydrochloride |
0.043 |
Down |
BCL2L10 |
Pyrimidine, 2-[1,5-bis(4-chlorophenyl)-1H-1,2,3-triazol-4-yl]- 1,4,5,6-tetrahydro- |
0.034 |
Up |
BCL2L10 |
3-Furancarbothioamide, [[3-(2-butenoxy)-4-methoxyphenyl]- 2-methyl- |
0.018 |
Down |
BCL2L10 |
NSC 651337 |
0.024 |
Down |
BCL2L10 |
NSC 651668 |
0.013 |
Down |
BCL2L10 |
ANTINEOPLASTIC-655905 |
0.035 |
Down |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:5
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:51
Total:4 Current:1
[First] [Prev]  Next Last 
|